Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized.
Callen
J P
JP
Division of Dermatology, University of Louisville School of Medicine, KY, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D001323:Autoantibodies / Q000032:analysis; D006657:Histones / Q000276:immunology; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D009281:Naphthalenes / Q000009:adverse effects; D000077291:Terbinafine
D000806:Angiotensin-Converting Enzyme Inhibitors; D001323:Autoantibodies; D006657:Histones; D009281:Naphthalenes; D006852:Hydrochlorothiazide; D000077291:Terbinafine